| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/10/2008 | EP1381629B1 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 09/10/2008 | EP1185665B1 INFECTIOUS cDNA CLONE OF GB VIRUS B AND USES THEREOF |
| 09/10/2008 | EP0905140B1 Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use |
| 09/10/2008 | CN101260411A Recombination bacillary viral vector skeleton plasmid and application thereof |
| 09/10/2008 | CN101260386A Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 09/10/2008 | CN101260385A Method for cultivating influenza virus |
| 09/10/2008 | CN100417722C Inactivating method for virus in blood products |
| 09/09/2008 | CA2144855C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 09/04/2008 | WO2008105934A2 Inactivation of toxic agents and pathogens using chitosan |
| 09/04/2008 | US20080214529 Such as n-{3-[1-(3,3-dimethyl-butyl)-4-hydroxy-2-oxo-1,2,4a,5,6,7-hexahydro-pyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxo-1,4-dihydro-1 lambda-6-benzo[1,2,4]thiadiazin-7-yl}-methane sulfonamide; hepatitis C viral infections; inhibiting replication |
| 09/04/2008 | US20080214471 Method for inhibition of viral infection |
| 09/04/2008 | US20080213863 Method of Controlling Viral Outbreak |
| 09/04/2008 | US20080213760 Compositions and methods for protein isolation |
| 09/04/2008 | US20080213752 Bacteriophages as Selective Agents |
| 09/04/2008 | US20080213309 Multi-antigenic alphavirus replicon particles and methods |
| 09/04/2008 | US20080213304 Immunogenic composition or vaccine of enteric reovirus strains; avian reovirus in a live, attenuated or killed form; veterinary medicine; twisted neck, tremors; poultry, fowl |
| 09/04/2008 | US20080213302 Methods for treating cancer with MVA |
| 09/04/2008 | US20080213290 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 09/04/2008 | US20080213222 Expression vector comprising nucleotide sequences coding factor IX for treatment of blood disorders |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | US20080213220 Adenovirus vector comprising progression elevated gene-3 (PEG-3) regulatory sequences and E1A tumor suppressor gene for use in targeted destruction of cancer cells; antiproliferative agents |
| 09/04/2008 | CA2663522A1 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| 09/03/2008 | EP1964573A2 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/03/2008 | EP1963495A2 An hiv-1 latency model for high throughput screening |
| 09/03/2008 | EP1963494A1 Phage particle diagnostic reagents |
| 09/03/2008 | EP1963003A2 Particle binding |
| 09/03/2008 | EP1180159B1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 09/03/2008 | EP1112371B1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 09/03/2008 | EP0789575B1 Peripheral nervous system specific sodium channels, dna encoding therefor, drug screening, and methods of making and using thereof |
| 09/03/2008 | CN101255442A LMP-1 recombinant gland related viral vectors as well as construction method and uses thereof |
| 09/03/2008 | CN101255441A AFP recombinant gland related viral vectors as well as construction method and uses thereof |
| 09/03/2008 | CN101255433A Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 09/03/2008 | CN100415891C Rabbit hemorrhagic disease vaccine and antigens |
| 09/03/2008 | CN100415876C Aids recombination gland virus vaccine |
| 09/03/2008 | CN100415298C Adenovirus vector for idiopathy liver genetherapy and using method |
| 09/02/2008 | US7419817 Using high performance liquid chromatography to isolate adeno-associated virus particles from cultures; genetic engineering and gene transfer tools |
| 09/02/2008 | US7419816 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 09/02/2008 | US7419808 Methods and compositions for the production of adenoviral vectors |
| 09/02/2008 | US7419802 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 09/02/2008 | US7419793 Flea octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/02/2008 | US7419674 Alpha virus-based cytomegalovirus vaccines |
| 09/02/2008 | CA2360012C Methods for the analysis of non-proteinaceous components using a protease from a bacillus strain |
| 09/02/2008 | CA2301067C Rapid cryobaric sterilization and vaccine preparation |
| 08/28/2008 | WO2008103380A2 Hepatitis b virus compositions and methods of use |
| 08/28/2008 | WO2007076101A3 Immunologically enhanced recombinant vaccines |
| 08/28/2008 | WO2007067818A3 Plasmids and packaging cell lines for use in phage display |
| 08/28/2008 | US20080206838 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| 08/28/2008 | US20080206837 Stable adenoviral vectors and methods for propagation thereof |
| 08/28/2008 | US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles |
| 08/28/2008 | US20080206742 Fragments of INI/hSNF5 that comprise the Rpt1 domain, inhibit HIV-1 replication, particle production, and cell-to-cell spread; antisense nucleotides; vectors; drug screening for anti-HIV drugs |
| 08/28/2008 | US20080206741 Virus Recovery Medium, Use Thereof and Viral Diagnostic Kit Including Same |
| 08/28/2008 | US20080206357 VIF as a traget for HIV inhibition |
| 08/28/2008 | US20080206283 Vaccine Against Sars |
| 08/28/2008 | US20080206282 Chimeric lyssavirus nucleic acids and polypeptides |
| 08/28/2008 | US20080206281 Method For Producing Storage Stable Viruses and Immunogenic Compositions Thereof |
| 08/28/2008 | US20080206279 Human cells comprising sequence encoding early region-1 (E1) gene product of an adenovirus; cultured in suspension to very high densities under serum-free conditions |
| 08/28/2008 | US20080206201 Oncolytic myxovirus for targeting and destroying cancer cell; antitumor agents; tissue targeted therapy |
| 08/28/2008 | US20080206199 Viral vector for target destruction of cancer cells |
| 08/28/2008 | US20080206197 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 08/28/2008 | CA2678966A1 Chimeric newcastle disease virus vlps |
| 08/27/2008 | EP1961814A1 Recombinant polyvalent vaccine |
| 08/27/2008 | EP1960526A2 Plasmids and packaging cell lines for use in phage display |
| 08/27/2008 | EP0931157B1 Retroviral vectors |
| 08/27/2008 | EP0826060B1 Embedded expression of heterologous proteins |
| 08/27/2008 | CN101253261A Diagnostic test kits |
| 08/27/2008 | CN101250503A In-vitro propagation method of tuberose virus |
| 08/27/2008 | CN101249261A Kidney syndrome hemorrhagic fever mucosa immune vaccines and method of preparing the same |
| 08/27/2008 | CN100413963C Producing method of gene recombination nucleopolyhedrosis virus pesticide and application thereof |
| 08/27/2008 | CN100413962C Extended-spectrum beta-lactamases Escherichia coli bacteriophage and its separation and preparation method |
| 08/26/2008 | US7416890 Baculovirus vector, method of producing thereof and method of gene transfer |
| 08/26/2008 | US7416846 A vaccine composition comprising virus-like particles (VLPs) containing L1 proteins or functional L1 protein derivatives from human papillomavirus (HPV) 16, HPV 18, HPV 31 and HPV 45 genotypes and an adjuvant;anticarcinogenic agents; antumor agents; viricides |
| 08/26/2008 | US7416842 Isolated nucleic acid molecule comprising the sequence of a DNA virus microRNA; Epstein barr virus; inhibiting microRNP activity in a cell |
| 08/26/2008 | US7416840 Cells and cell lines which replicate HCV of non-hepatic human and non human origin; screening an agent that modulates HCV replication; HCV derived polynucleotides comprising adaptive mutations and polypeptides encoding them |
| 08/26/2008 | US7416732 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 08/21/2008 | WO2008100273A1 Novel listeria monocytogenes bacteriophage and uses thereof |
| 08/21/2008 | WO2007140011A3 Erythroid progenitor cells and methods for producing parvovirus b19 therein |
| 08/21/2008 | WO2006096459A3 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 08/21/2008 | US20080199939 Recombinant, replication defective viral particles comprising chimeric hexon protein and hyper variable regions for use in improved gene delivery, vaccination, and gene therapy |
| 08/21/2008 | US20080199445 Compositions and methods for treatment of microbial infections |
| 08/21/2008 | US20080199442 Gene linked to control elements capable of directing in vivo transcription and translation; systemic delivery of erythropoietin |
| 08/21/2008 | US20080199433 Complementing cell lines |
| 08/21/2008 | US20080199424 Mart-1 t cell receptors |
| 08/21/2008 | CA2664791A1 Recombinant rhinovirus vectors |
| 08/20/2008 | EP1958956A2 Peptidomimetic protease inhibitors |
| 08/20/2008 | EP1958626A1 Method for inactivating viruses by addition of slightly acidic arginine |
| 08/20/2008 | EP1497440B1 Stable adenoviral vectors and methods for propagation thereof |
| 08/20/2008 | EP1496944B1 Improved raav expression systems for genetic modification of specific capsid proteins |
| 08/20/2008 | EP1142473B1 Compositions for acquiring immunological tolerance |
| 08/20/2008 | EP0809704B1 Method for preparing a recombinant adenovirus genome |
| 08/20/2008 | EP0797660B1 Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants |
| 08/20/2008 | EP0587780B2 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 08/20/2008 | CN101248174A Attenuated SARS and use as a vaccine |
| 08/20/2008 | CN101248173A Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 08/20/2008 | CN101245326A Concentration method for virus or bacteria |
| 08/20/2008 | CN100412201C Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 08/20/2008 | CN100412190C Hepatitis B virus complete-genome polymerase chimera construction process and application |
| 08/20/2008 | CN100412089C Full-length infectious CDNA clones of tick borne flavivirus |
| 08/19/2008 | US7414108 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation. |
| 08/19/2008 | US7413889 Production of a parvovirus vaccine in plants as viral coat protein fusions |
| 08/19/2008 | US7413882 Methods for degrading or converting plant cell wall polysaccharides |